This is my first contribution to GNBT investors ha
Post# of 36537
(Total Views: 572)
Posted On: 05/20/2021 4:17:00 PM
This is my first contribution to GNBT investors hangout, I am an investor in GNBT since 1 and a half years. I would believe that filing the S1 FORM to SEC is really a great step for GNBT sharesholders which I think it is the main investment for all of you guys here.I believe Once the IPO date is announced this might trigger the market awareness to GNBT as a holding company, its products pipeline and great potential associated in it.
I haven't seen anything in the S1 FORM that would be considered awkward or unusual compared to common practices used by investment houses to protect the interest of the related publicly offered companies and the new investors whom will be bidding to buy the publicly offered shares, I think if you dig deep in any IPO Prospectous you will have a lot of comments and raised questions which is related to all kinds of legal and regulatory regulations and practices .... etc
As for us the current shareholders of GNBT we need to concentrate on the main news the IPO and its impact on GNBT stock price in the coming period. We should look at the public offering of NGIO as a confirmation from the SEC that GNBT is fulfilling the needed requirements and a further step toward reallocating GNBT back to NAZ.
On the other hand once the IPO date is announced this will build the market awareness toward the complete vaccine process and the other products within the pipeline of GNBT and its sister companies.
I would believe that the coming quarter is holding a great potential to build the price appreciation, of course it depends on GNBT management and their marketing and PR strategy as it will be an essential element for the coming period.
Wishing the best for all of us in the coming exciting quarter.
I haven't seen anything in the S1 FORM that would be considered awkward or unusual compared to common practices used by investment houses to protect the interest of the related publicly offered companies and the new investors whom will be bidding to buy the publicly offered shares, I think if you dig deep in any IPO Prospectous you will have a lot of comments and raised questions which is related to all kinds of legal and regulatory regulations and practices .... etc
As for us the current shareholders of GNBT we need to concentrate on the main news the IPO and its impact on GNBT stock price in the coming period. We should look at the public offering of NGIO as a confirmation from the SEC that GNBT is fulfilling the needed requirements and a further step toward reallocating GNBT back to NAZ.
On the other hand once the IPO date is announced this will build the market awareness toward the complete vaccine process and the other products within the pipeline of GNBT and its sister companies.
I would believe that the coming quarter is holding a great potential to build the price appreciation, of course it depends on GNBT management and their marketing and PR strategy as it will be an essential element for the coming period.
Wishing the best for all of us in the coming exciting quarter.
(11)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼